Yan Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yan Shi has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Melanie D. Desrosiers
Immunology Research Group and Department of Microbiology and Infectious Diseases, University of Calgary, Calgary, Alta., Canada
3 shared publicationsAshley D. Mucsi
Immunology Research Group and Department of Microbiology and Infectious Diseases, University of Calgary, Calgary, Alta., Canada
2 shared publicationsGilbert Ng
Department of Microbiology and Infectious Diseases, and Immunology Research Group, Faculty of Medicine, University of Calgary, Calgary, AB, Canada
2 shared publicationsKaran Sharma
Immunology Research Group and Department of Microbiology and Infectious Diseases, University of Calgary , Calgary, Alberta
2 shared publicationsAilian Yang
Immunology Research Group and Department of Microbiology and Infectious Diseases, University of Calgary, Calgary, Alta., Canada
1 shared publicationChang-Chun Ling
Department of Chemistry, University of Calgary, Calgary, Alberta T2N 4N1, Canada
1 shared publication
Latest Publications
- 14 January 2011
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 13 (2) , 160-166
The Role of Uric Acid as an Endogenous Danger Signal in Immunity and Inflammation
Gout is an ancient disease that still plagues us. Its pathogenic culprit, uric acid crystal deposition in tissues, is a strong inflammatory stimulant. In recent years, the mechanisms through which uric acid crystals promote inflammation have been a subject of increasing interest among rheumatologists and immunologists. Uric acid has been identified as an endogenous adjuvant that drives immune responses in the absence of microbial stimulation. Because uric acid is a ubiquitous metabolite that is produced in high quantities upon cellular injury, the ramifications of its effects may be considerable in health and in disease. Uric acid crystals also have been shown to trigger interleukin-1β–mediated inflammation via activation of the NOD-like receptor protein (NLRP)3 inflammasome, a multimolecular complex whose activation appears to be central to many pathological inflammatory conditions. In this article, we review the possible mechanisms of uric acid–mediated inflammation and offer some historical perspectives on what has been learned about the complex effects of a relatively simple substance.
- 14 January 2011
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 13 (2) , 160-166
The Role of Uric Acid as an Endogenous Danger Signal in Immunity and Inflammation
Gout is an ancient disease that still plagues us. Its pathogenic culprit, uric acid crystal deposition in tissues, is a strong inflammatory stimulant. In recent years, the mechanisms through which uric acid crystals promote inflammation have been a subject of increasing interest among rheumatologists and immunologists. Uric acid has been identified as an endogenous adjuvant that drives immune responses in the absence of microbial stimulation. Because uric acid is a ubiquitous metabolite that is produced in high quantities upon cellular injury, the ramifications of its effects may be considerable in health and in disease. Uric acid crystals also have been shown to trigger interleukin-1β–mediated inflammation via activation of the NOD-like receptor protein (NLRP)3 inflammasome, a multimolecular complex whose activation appears to be central to many pathological inflammatory conditions. In this article, we review the possible mechanisms of uric acid–mediated inflammation and offer some historical perspectives on what has been learned about the complex effects of a relatively simple substance.
- Open Access
- 1 June 2010
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 120 (6) , 1809-1811
Caught red-handed: uric acid is an agent of inflammation
Inflammation occurs in response to both pathogenic insult and tissue damage under sterile conditions, with the latter contributing to the pathogenesis of many diseases. Although several endogenous substances, including uric acid, have been suggested to alert the body to danger and to stimulate inflammation, little is known about their contribution to such responses in vivo. In this issue of the JCI, Kono et al. use newly generated mice with reduced levels of uric acid to investigate its role as an endogenous signal of tissue damage in inflammatory responses to hepatic injury. They find that uric acid is released from dying tissues and induces inflammation to cell death but is not involved in the response to microbial molecules or sterile irritant particles. I believe this to be the first report of an endogenous danger signal acting as a physiological regulator of inflammation.
- 1 June 2010
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 120 (6) , 1809-1811
Open AccessCaught red-handed: uric acid is an agent of inflammation
Inflammation occurs in response to both pathogenic insult and tissue damage under sterile conditions, with the latter contributing to the pathogenesis of many diseases. Although several endogenous substances, including uric acid, have been suggested to alert the body to danger and to stimulate inflammation, little is known about their contribution to such responses in vivo. In this issue of the JCI, Kono et al. use newly generated mice with reduced levels of uric acid to investigate its role as an endogenous signal of tissue damage in inflammatory responses to hepatic injury. They find that uric acid is released from dying tissues and induces inflammation to cell death but is not involved in the response to microbial molecules or sterile irritant particles. I believe this to be the first report of an endogenous danger signal acting as a physiological regulator of inflammation.
- Open Access
- 26 January 2010
- Published by Wiley in European Journal of Immunology
- Vol. 40 (2) , 449-459
Adenosine mediated desensitization of cAMP signaling enhances T‐cell responses
Adenosine has long been regarded as a crucial anti‐inflammatory agent that protects the host from excessive damage. It has been reported to play an important role in suppressing immune activation, particularly that of T cells. However, it is a general observation that induction of T‐cell activation is an efficient event despite the high adenosine levels that are often present in the affected host due to injury or stress. We report here that prior to antigenic stimulationviaTCR/CD3, exposure of T cells to adenosine desensitizes adenosine receptors, so as to create a window of time where the T cells are insensitive to this ubiquitous suppressor. T cells from mice that were pre‐exposed to this manipulation showed stronger responses to antigenic stimulation; therefore, the P1 adenosine receptor desensitization demonstrated an adjuvant‐like effect. Our results suggest that adenosine receptor desensitization may be a mechanism for T cells to escape the general suppression during early points of T‐cell activation and may emerge as a potential alternative for vaccine adjuvants.
- 26 January 2010
- Published by Wiley in European Journal of Immunology
- Vol. 40 (2) , 449-459
Open AccessAdenosine mediated desensitization of cAMP signaling enhances T‐cell responses
Adenosine has long been regarded as a crucial anti‐inflammatory agent that protects the host from excessive damage. It has been reported to play an important role in suppressing immune activation, particularly that of T cells. However, it is a general observation that induction of T‐cell activation is an efficient event despite the high adenosine levels that are often present in the affected host due to injury or stress. We report here that prior to antigenic stimulationviaTCR/CD3, exposure of T cells to adenosine desensitizes adenosine receptors, so as to create a window of time where the T cells are insensitive to this ubiquitous suppressor. T cells from mice that were pre‐exposed to this manipulation showed stronger responses to antigenic stimulation; therefore, the P1 adenosine receptor desensitization demonstrated an adjuvant‐like effect. Our results suggest that adenosine receptor desensitization may be a mechanism for T cells to escape the general suppression during early points of T‐cell activation and may emerge as a potential alternative for vaccine adjuvants.
- 23 December 2009
- Published by Wiley in Immunological Reviews
- Vol. 233 (1) , 203-217
Monosodium urate crystals in inflammation and immunity
Summary: Uric acid crystals [monosodium urate (MSU)] have emerged as an important factor for both gouty arthritis and immune regulation. This simple crystalline structure appears to activate innate host defense mechanisms in multiple ways and triggers robust inflammation and immune activation. The recognition mechanisms of MSU following its phase change from soluble uric acid are diverse, involving both protein receptors and non‐specific plasma membrane attachment. Upon contact with host cells, MSU induces a set of membrane events that trigger Syk and PI3K activation, phagocytosis, and cytokine production. Having entered the cell, MSU further triggers NALP3 inflammasome activation and induces the production of IL‐1β, likely inducing a full spectrum of inflammation. This review describes the recognition mechanisms and activation pathways involved in MSU‐mediated inflammation and adjuvanticity and hypothesizes that direct membrane binding by solid surfaces, such as MSU, may function as a generic mechanism in tissue responses to particulate and crystalline structures.
- 23 December 2009
- Published by Wiley in Immunological Reviews
- Vol. 233 (1) , 203-217
Monosodium urate crystals in inflammation and immunity
Summary: Uric acid crystals [monosodium urate (MSU)] have emerged as an important factor for both gouty arthritis and immune regulation. This simple crystalline structure appears to activate innate host defense mechanisms in multiple ways and triggers robust inflammation and immune activation. The recognition mechanisms of MSU following its phase change from soluble uric acid are diverse, involving both protein receptors and non‐specific plasma membrane attachment. Upon contact with host cells, MSU induces a set of membrane events that trigger Syk and PI3K activation, phagocytosis, and cytokine production. Having entered the cell, MSU further triggers NALP3 inflammasome activation and induces the production of IL‐1β, likely inducing a full spectrum of inflammation. This review describes the recognition mechanisms and activation pathways involved in MSU‐mediated inflammation and adjuvanticity and hypothesizes that direct membrane binding by solid surfaces, such as MSU, may function as a generic mechanism in tissue responses to particulate and crystalline structures.
- 1 March 2009
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 380 (4) , 748-751
Adenosine primes resting stage dendritic cells before their activation
- 1 March 2009
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 380 (4) , 748-751
Adenosine primes resting stage dendritic cells before their activation
- 15 February 2009
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 182 (4) , 1912-1918
A Role of IgM Antibodies in Monosodium Urate Crystal Formation and Associated Adjuvanticity
Uric acid is released from injured cells and can act as an adjuvant signal to the immune system. Uric acid crystals invoke strong inflammatory responses in tissues. Although their biological effects are evident and the associated signaling mechanisms are becoming clear, it remains unexplained as to why uric acid precipitates rapidly in vivo, in sharp contrast to the minimal crystallization in vitro. We report in this study that a group of IgM Abs is able to bind to these crystals, which is interesting in light that B cell-deficient mice do not sense the proinflammatory adjuvant effect of uric acid. The titers of these Abs increase upon immunization with uric acid crystals. We have produced large quantities of such mAbs. The purified IgM Abs can significantly facilitate uric acid precipitation to form the inflammatory crystals in vitro. Infusion of these Abs into B cell-deficient mice significantly increases the basal level of inflammation in these recipients and restores the host’s ability to sense uric acid’s adjuvanticity. Therefore, we have identified a factor in determining uric acid precipitation and possibly its ability to function as an endogenous adjuvant. This finding suggests a new mechanism of the pathogenesis of gouty arthritis and uric acid-induced immune activation.
- 15 February 2009
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 182 (4) , 1912-1918
A Role of IgM Antibodies in Monosodium Urate Crystal Formation and Associated Adjuvanticity
Uric acid is released from injured cells and can act as an adjuvant signal to the immune system. Uric acid crystals invoke strong inflammatory responses in tissues. Although their biological effects are evident and the associated signaling mechanisms are becoming clear, it remains unexplained as to why uric acid precipitates rapidly in vivo, in sharp contrast to the minimal crystallization in vitro. We report in this study that a group of IgM Abs is able to bind to these crystals, which is interesting in light that B cell-deficient mice do not sense the proinflammatory adjuvant effect of uric acid. The titers of these Abs increase upon immunization with uric acid crystals. We have produced large quantities of such mAbs. The purified IgM Abs can significantly facilitate uric acid precipitation to form the inflammatory crystals in vitro. Infusion of these Abs into B cell-deficient mice significantly increases the basal level of inflammation in these recipients and restores the host’s ability to sense uric acid’s adjuvanticity. Therefore, we have identified a factor in determining uric acid precipitation and possibly its ability to function as an endogenous adjuvant. This finding suggests a new mechanism of the pathogenesis of gouty arthritis and uric acid-induced immune activation.